Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY17.30 CNY
Change Today +0.10 / 0.58%
Volume 7.0M
300086 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

hainan honz pharmaceutical-a (300086) Snapshot

Open
CNY17.20
Previous Close
CNY17.20
Day High
CNY17.31
Day Low
CNY17.06
52 Week High
03/17/15 - CNY18.78
52 Week Low
04/28/14 - CNY9.92
Market Cap
5.2B
Average Volume 10 Days
13.8M
EPS TTM
CNY0.11
Shares Outstanding
300.0M
EX-Date
05/23/14
P/E TM
162.9x
Dividend
CNY0.13
Dividend Yield
0.77%
Current Stock Chart for HAINAN HONZ PHARMACEUTICAL-A (300086)

Related News

No related news articles were found.

hainan honz pharmaceutical-a (300086) Related Businessweek News

No Related Businessweek News Found

hainan honz pharmaceutical-a (300086) Details

HaiNan Honz Pharmaceutical Co.,Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products with a focus on children health in China. It offers chemical and traditional Chinese medicines in the areas of antipyretic analgesics, cold, antibiotics, antianaphylaxis, digestive aids, and nutrition boosters. The company's chemical medicine products include Ribavirin granules to treat respiratory syncytial virus-related diseases; Cefaclor granules for the treatment of various kinds of infections by sensitive bacteria; Lacidophilin granules for diarrhea indigestion and enteritis; Ibuprofen granules to alleviate mild to moderate pain; Co.Paracetamol granules for the treatment of common cold or influenza in children; and Albumin Tannate and Barm powder used for the treatment of diarrhea caused by indigestion and enteritis. Its traditional Chinese medicines comprise Xiao'er fuxie powder to treat diarrhea and associated symptoms; Xiao'er Magan and Zhike Juhong granules to relieve coughs and reduce phlegm; Jian'erle granules for indigestion treatment; and Xiao'er Qingjie granules to bring down fever and relieve irritation, dry mouth, sore throats, and muscle aches. The company is headquartered in Guangzhou, China.

hainan honz pharmaceutical-a (300086) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hainan honz pharmaceutical-a (300086) Key Developments

Hainan Honz Pharmaceutical Co., Ltd. Approves Amendments to the Articles of Association

Hainan Honz Pharmaceutical Co., Ltd. approved amendments to the articles of association of the company at its first extraordinary general meeting of 2015 held on February 11, 2015.

Hainan Honz Pharmaceutical Co., Ltd. Proposes Amendments to its Articles of Association

Hainan Honz Pharmaceutical Co., Ltd. at its 1st extraordinary general meeting of 2015 to be held on February 11, 2015, it will proposed amendments to the articles of association of the company.

Hainan Honz Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Feb 11, 2015

Hainan Honz Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Feb 11, 2015., at 10:00 China Standard Time. Agenda: To consider the amendments to the raised fund management system; to consider the use of partial idle raised funds for cash management; to consider the amendments to the articles of association of the company; to consider the amendments to the company's rules of procedures governing shareholders' general meetings; to consider the amendments to the company's rules of procedures governing the board meetings; to consider the first phase employee shareholding plan (draft) and its summary; and to consider the authorization to the board to handle matters in relation to the first phase employee shareholding plan.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300086:CH CNY17.30 CNY +0.10

300086 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Pediatric Pharmaceuticals Inc $0.07 USD 0.00
View Industry Companies
 

Industry Analysis

300086

Industry Average

Valuation 300086 Industry Range
Price/Earnings 90.4x
Price/Sales 12.7x
Price/Book 2.7x
Price/Cash Flow 89.6x
TEV/Sales 9.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAINAN HONZ PHARMACEUTICAL-A, please visit www.honz.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.